SPRB logo

Spruce Biosciences (SPRB) Cash From Operations

Annual CFO

-$33.27 M
+$8.41 M+20.17%

December 31, 2023


Summary


Performance

SPRB Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRBcash flowmetrics:

Quarterly CFO

-$9.22 M
+$1.88 M+16.95%

September 30, 2024


Summary


Performance

SPRB Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRBcash flowmetrics:

TTM CFO

-$46.50 M
+$3.05 M+6.15%

September 30, 2024


Summary


Performance

SPRB TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRBcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SPRB Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.2%+17.7%-39.7%
3 y3 years-20.9%+17.7%-39.7%
5 y5 years-288.3%+17.7%-39.7%

SPRB Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+20.2%-562.8%+38.3%-54.4%+6.2%
5 y5-year-163.7%+20.2%-562.8%+38.3%-680.7%+6.2%
alltimeall time-288.3%+20.2%-562.8%+38.3%-680.7%+6.2%

Spruce Biosciences Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.22 M(-17.0%)
-$46.50 M(-6.1%)
Jun 2024
-
-$11.11 M(-25.8%)
-$49.54 M(+35.9%)
Mar 2024
-
-$14.96 M(+33.4%)
-$36.44 M(+9.5%)
Dec 2023
-$33.27 M(-20.2%)
-$11.21 M(-8.6%)
-$33.27 M(-1.6%)
Sep 2023
-
-$12.27 M(-715.6%)
-$33.80 M(+12.3%)
Jun 2023
-
$1.99 M(-116.9%)
-$30.11 M(-27.7%)
Mar 2023
-
-$11.79 M(+0.4%)
-$41.65 M(-0.1%)
Dec 2022
-$41.68 M
-$11.74 M(+36.8%)
-$41.68 M(+4.9%)
Sep 2022
-
-$8.58 M(-10.1%)
-$39.74 M(+2.5%)
Jun 2022
-
-$9.54 M(-19.3%)
-$38.76 M(-0.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$11.83 M(+20.7%)
-$38.92 M(+8.5%)
Dec 2021
-$35.88 M(+30.4%)
-$9.80 M(+29.0%)
-$35.88 M(+1.5%)
Sep 2021
-
-$7.60 M(-21.6%)
-$35.34 M(0.0%)
Jun 2021
-
-$9.69 M(+10.3%)
-$35.34 M(+16.5%)
Mar 2021
-
-$8.79 M(-5.2%)
-$30.35 M(+10.3%)
Dec 2020
-$27.52 M(+118.1%)
-$9.27 M(+22.0%)
-$27.52 M(+50.8%)
Sep 2020
-
-$7.60 M(+61.6%)
-$18.25 M(+71.3%)
Jun 2020
-
-$4.70 M(-21.1%)
-$10.66 M(+78.9%)
Mar 2020
-
-$5.96 M
-$5.96 M
Dec 2019
-$12.62 M(+47.2%)
-
-
Dec 2018
-$8.57 M
-
-

FAQ

  • What is Spruce Biosciences annual cash flow from operations?
  • What is the all time high annual CFO for Spruce Biosciences?
  • What is Spruce Biosciences annual CFO year-on-year change?
  • What is Spruce Biosciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Spruce Biosciences?
  • What is Spruce Biosciences quarterly CFO year-on-year change?
  • What is Spruce Biosciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Spruce Biosciences?
  • What is Spruce Biosciences TTM CFO year-on-year change?

What is Spruce Biosciences annual cash flow from operations?

The current annual CFO of SPRB is -$33.27 M

What is the all time high annual CFO for Spruce Biosciences?

Spruce Biosciences all-time high annual cash flow from operations is -$8.57 M

What is Spruce Biosciences annual CFO year-on-year change?

Over the past year, SPRB annual cash flow from operations has changed by +$8.41 M (+20.17%)

What is Spruce Biosciences quarterly cash flow from operations?

The current quarterly CFO of SPRB is -$9.22 M

What is the all time high quarterly CFO for Spruce Biosciences?

Spruce Biosciences all-time high quarterly cash flow from operations is $1.99 M

What is Spruce Biosciences quarterly CFO year-on-year change?

Over the past year, SPRB quarterly cash flow from operations has changed by +$1.99 M (+17.72%)

What is Spruce Biosciences TTM cash flow from operations?

The current TTM CFO of SPRB is -$46.50 M

What is the all time high TTM CFO for Spruce Biosciences?

Spruce Biosciences all-time high TTM cash flow from operations is -$5.96 M

What is Spruce Biosciences TTM CFO year-on-year change?

Over the past year, SPRB TTM cash flow from operations has changed by -$13.22 M (-39.73%)